MedC Biopharma

About

Funding history · 1 round · $5.0M total

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is the current operational status of MedC Biopharma?

MedC Biopharma is currently inactive, having ceased operations in March 2023.

When was MedC Biopharma founded and what was its primary focus?

MedC Biopharma was founded in July 2016 and focused on developing cannabis-based treatments for cancer, specifically for cutaneous T-cell lymphoma.

What was the total funding raised by MedC Biopharma and when was its last funding round?

MedC Biopharma raised a total of $5,000,000. Its last funding round was a Series A in September 2018, with AgMedica Bioscience Inc. as an investor. For a full financing history, please refer to startupim.

Which organizations collaborated with MedC Biopharma on research published in Oncotarget in June 2020?

In June 2020, MedC Biopharma collaborated with ARO Volcani Centre and Rabin Medical Centre on research published in the peer-reviewed scientific journal Oncotarget.

Did MedC Biopharma announce any partnerships in early 2021?

Yes, in January 2021, MedC Biopharma announced a partnership with Sana Healthcare to advance its skin oncology platform.

What was the nature of MedC Biopharma's R&D efforts?

MedC Biopharma's R&D was based on a combined effort with Professor Hinanit Koltai from ARO, Israel, and Professor Emmilia Hodek from Rabin Medical Center, Israel, focusing on a novel treatment for cutaneous T-cell lymphoma and other skin oncology and anxiety-related indications.

Where were MedC Biopharma's main offices located?

MedC Biopharma had its headquarters in Rishon LeTsiyon, Israel, and an additional office in Toronto, Canada.

What was the approximate employee count for MedC Biopharma?

MedC Biopharma had an employee count in the range of 11-50.

Sectors & technology

Highlights

Tags